Details for 2016710891

Up to date per 02.04.2026

Actions

Title / Product Name

KOMBINATION AUS PEMBROLIZUMAB UND ERIBULIN ZUR BEHANDLUNG VON TRIPLE-NEGATIVEM BRUSTKREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016710891

EP Publication Number

3265122

E-Number

1488322

Language

PCT Number

US16020734

Publication Date

10.01.2018 A

04.05.2022 B1

Registration Date

04.05.2022

AT Publication Date

15.05.2022

Application Date

03.03.2016

Registration Number

Priorities

04.03.2015

201562128373 P

07.12.2015

201562264068 P

IPC

A61K 39/395 20060101AFI20160915BHEP

Maximum Duration of Protection

03.03.2036

Owner

Merck Sharp & Dohme Corp.126 East Lincoln Avenue Rahway, NJ 07065US

Eisai R&D Management Co., Ltd.6-10, Koishikawa 4-chome Bunkyo-ku Tokyo 112-8088JP

Representative

No representatives present

Inventor

MATSUI, Junjic/o Eisai Co., Ltd. 1-3 Tokodai 5-Chome Tsukuba-shi Ibaraki 300-2635JP

AKTAN, Gursel351 North Sumneytown Pike North Wales, PA 19454US

KARANTZA, Vassiliki126 E. Lincoln Avenue Rahway, NJ 07065US

YUAN, RuiRong4 Horizon Rd. Apt. 620 Fort Lee, NJ 07024US

FUNAHASHI, Yasuhiroc/o Eisai Co., Ltd. 1-3 Tokodai 5-Chome Tsukuba-shi, Ibaraki 300-2635JP

BERRAK, Erhan217 Sunrise Court River Vale, NJ 07675US